PD-161570  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 10mg 25mg 50mg 100mg in glass bottle
溶解性:溶于DMSO(30mg/ml超声)
产品描述:基本信息 产品编号:P11676 产品名称:PD-161570 CAS: 192705-80-9   储存条件 粉末 -20℃ 四年     分子式: C26H35Cl2N7O 溶于液体 -80℃ 六个月 分子量 532.51 -20℃ 一个月 化学名:      制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 1.8779mL 9.3895mL 18.7790mL 5mM 0.3756mL 1.8779mL 3.7558mL 10mM 0.1878mL 0.9389mL 1.8779mL   生物活性 产品描述 一种有效的且具有ATP竞争能力的人FGF-1受体抑制剂,还抑制PDGFR,EGFR和c-Src酪氨酸激酶,抑制PDGF刺激的自磷酸化和FGF-1受体磷酸化,还是一种骨形态发生蛋白(BMPs)和TGF-β信号抑制剂。 靶点/IC50 FGFR1 39.9nM (IC50) FGFR1 42nM (Ki) FGFR1 autophosphorylation 622nM (IC50) PDGFRβ 262nM (IC50) PDGFR 310nM (IC50) EGFR 240nM (IC50) c-Src 44nM (IC50) TGF-β Receptor   体外研究 PD-161570 (Compound 6c; 0.1-1µM; 1-8 days; VSMCs) treatment inhibits PDGF-stimulated vascular smooth muscle cellproliferation in a dose dependent fashion with an IC50 of 0.3µM on day 8. PD-161570 suppresses constitutive phosphorylation of the FGF-1 receptor in both human ovarian carcinoma cells (A121(p)) and Sf9 insect cells overexpressing the human FGF-1 receptor and blocked the growth of A121(p) cells in culture. PD-161570 can potently inhibit basic fibroblast growth factor (bFGF)-mediated angiogenesis. Cell Proliferation Assay Cell Line: Vascular smooth muscles cells (VSMCs) Concentration: 0.1µM, 0.3µM, 1µM Incubation Time: 1 day, 3 days, 6 days, 8 days Result: Inhibited VSMC proliferation in a dose dependent fashion with an IC50 of 0.3µM at day 8.
保存条件:-20℃